Mark Davison

Senior Operations Director – Europe

rfXcel

Head of Europe for rfxcel Corporation – global leader in traceability solutions for FMD, DSCSA and other regs. Started EU and Russia operations from zero, devising regional strategy, hiring staff and managing fast growth.

Voted onto Medicine Maker magazine’s Power List of 100 most influential people in pharma manufacturing and development. Globally experienced entrepreneur, start-up executive, book author (Wiley).

Board-level operator specializing in strategic global health and big data issues such as serialization, supply chain security, patient safety and government policy but wide experience elsewhere including due diligence and international business development.

Expert in legislation and its impact: EU Falsified Medicines Directive, US initiatives including Drug Quality and Security Act (DQSA, DSCSA), emerging laws in Argentina, Brazil, China, India, Korea, Turkey etc.

Technical expertise in anti-counterfeiting technologies and vendor selection, including authentication, serialization, traceability. Pharmaceuticals, medical devices, food and beverage sector experience with core expertise in anti-counterfeiting technologies that transfers well to other industries such as luxury goods, clothing, consumer goods.

Based in the UK, with wide experience in Europe, Africa, Asia (inc. Japan & China), North and South America. Training in biochemistry, microbiology, R&D project management. Followed by various commercial roles in CROs, consultancy and CEO roles in micro-start-up environment and virtual drug development. Interested in use of big data and mobile technology to protect patients and improve health outcomes, especially in the developing world.

MARK DAVISON

Senior Operations Director – Europe

rfXcel

Find MARK on LinkedIn

BIOGRAPHY

Head of Europe for rfxcel Corporation – global leader in traceability solutions for FMD, DSCSA and other regs. Started EU and Russia operations from zero, devising regional strategy, hiring staff and managing fast growth. Voted onto Medicine Maker magazine’s Power List of 100 most influential people in pharma manufacturing and development. Globally experienced entrepreneur, start-up executive, book author (Wiley).

Board-level operator specializing in strategic global health and big data issues such as serialization, supply chain security, patient safety and government policy but wide experience elsewhere including due diligence and international business development.

Expert in legislation and its impact: EU Falsified Medicines Directive, US initiatives including Drug Quality and Security Act (DQSA, DSCSA), emerging laws in Argentina, Brazil, China, India, Korea, Turkey etc.

Technical expertise in anti-counterfeiting technologies and vendor selection, including authentication, serialization, traceability. Pharmaceuticals, medical devices, food and beverage sector experience with core expertise in anti-counterfeiting technologies that transfers well to other industries such as luxury goods, clothing, consumer goods.

Based in the UK, with wide experience in Europe, Africa, Asia (inc. Japan & China), North and South America. Training in biochemistry, microbiology, R&D project management. Followed by various commercial roles in CROs, consultancy and CEO roles in micro-start-up environment and virtual drug development. Interested in use of big data and mobile technology to protect patients and improve health outcomes, especially in the developing world.